FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2132201 · Received June 13, 2011

Report

Report Number
2953161-2011-00138
Event Type
Injury
Date Received
June 13, 2011
Date of Event
May 18, 2011
Report Date
June 13, 2011
Manufacturer
W. L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. ANEURYSM GROWTH IN THE ABSENCE OF ENDOLEAK HAS BEEN DEFINED AS ENDOTENSION. ONE HYPOTHESIS FOR THE SOURCE OF ENDOTENSION IS THE TRANSMURAL MOVEMENT OF SERIOUS FLUID ACROSS THE MATERIAL USED TO FABRICATE DEVICES USED TO TREAT THE AORTIC ABDOMINAL ANEURYSM. IN RESPONSE TO THIS ISSUE, GORE ELECTED TO PROVIDE A DESIGN ENHANCEMENT TO THE ORIGINAL GORE EXCLUDER BIFURCATED ENDOPROSTHESIS.

Description of Event or Problem · 1

ON (B)(6) 2003, THIS PT WAS IMPLANTED WITH GORE EXCLUDER BIFURCATED ENDOPROSTHESIS FOR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM. APPROX TWO WEEKS BEFORE REINTERVENTION, CT SCAN REVEALED ANEURYSM GROWTH WITH NO SIGN OF ENDOLEAK. ON (B)(6) 2011, THIS PT HAD A REINTERVENTION TO TREAT ANEURYSM GROWTH WITH NO SIGN OF ENDOLEAK. ADDITIONAL GORE EXCLUDER AAA ENDOPROSTHESES WERE IMPLANTED TO RELINE THE GRAFT. THE PT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES WLG425 032090601

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R PCL161407/(B)(4)| PCA280300/(B)(4)| PCC201400/(B)(4)| PCC201200/(B)(4)| PCA280300/(B)(4)| PCL161407/(B)(4)